BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Koutsounas I, Giaginis C, Patsouris E, Theocharis S. Current evidence for histone deacetylase inhibitors in pancreatic cancer. World J Gastroenterol 2013; 19(6): 813-828 [PMID: 23430136 DOI: 10.3748/wjg.v19.i6.813]
URL: https://www.wjgnet.com/1007-9327/full/v19/i6/813.htm
Number Citing Articles
1
Fouad Choueiry, Molly Torok, Reena Shakya, Kriti Agrawal, Anna Deems, Brooke Benner, Alice Hinton, Jami Shaffer, Bradley W Blaser, Anne M Noonan, Terence M Williams, Mary Dillhoff, Darwin L Conwell, Phil A Hart, Zobeida Cruz-Monserrate, Xue-Feng Bai, William E Carson III, Thomas A Mace. CD200 promotes immunosuppression in the pancreatic tumor microenvironmentJournal for ImmunoTherapy of Cancer 2020; 8(1): e000189 doi: 10.1136/jitc-2019-000189
2
Hua Zhang, Xufeng Dai, Yan Qi, Ying He, Wei Du, Ji-jing Pang. Histone Deacetylases Inhibitors in the Treatment of Retinal Degenerative Diseases: Overview and PerspectivesJournal of Ophthalmology 2015; 2015: 1 doi: 10.1155/2015/250812
3
Jingjing Gong, Amanda R. Muñoz, Daniel Chan, Rita Ghosh, Addanki P. Kumar. STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growthOncotarget 2014; 5(9): 2529 doi: 10.18632/oncotarget.1810
4
Dinesh Kumar, Pranjal Sarma, Manika P. Bhadra, Anjana D. Tangutur. Impact of Hybrid-polar Histone Deacetylase Inhibitor m-Carboxycinnamic Acid bis-Hydroxyamide on Human Pancreatic Adenocarcinoma CellsAnti-Cancer Agents in Medicinal Chemistry 2019; 19(6): 750 doi: 10.2174/1871520619666190101115034
5
Ei Nakajima, Kouhei Shimaji, Takanari Umegawachi, Saki Tomida, Hideki Yoshida, Nana Yoshimoto, Shingo Izawa, Hiroshi Kimura, Masamitsu Yamaguchi, Efthimios M. C. Skoulakis. The Histone Deacetylase Gene Rpd3 Is Required for Starvation Stress ResistancePLOS ONE 2016; 11(12): e0167554 doi: 10.1371/journal.pone.0167554
6
Richard S. Laschanzky, Lisa E. Humphrey, Jihyun Ma, Lynette M. Smith, Thomas J. Enke, Surendra K. Shukla, Aneesha Dasgupta, Pankaj K. Singh, Gillian M. Howell, Michael G. Brattain, Quan P. Ly, Adrian R. Black, Jennifer D. Black. Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer TherapyCancers 2019; 11(9): 1327 doi: 10.3390/cancers11091327
7
Maïté Rielland, David J. Cantor, Richard Graveline, Cristina Hajdu, Lisa Mara, Beatriz de Diego Diaz, George Miller, Gregory David. Senescence-associated SIN3B promotes inflammation and pancreatic cancer progressionJournal of Clinical Investigation 2014; 124(5): 2125 doi: 10.1172/JCI72619
8
Zhao-Chun Chi. Research status and prgoress of nonalcoholic fatty pancreatic diseaseWorld Chinese Journal of Digestology 2020; 28(19): 933 doi: 10.11569/wcjd.v28.i19.933
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
9
Wan Feng, Bin Zhang, Dawei Cai, Xiaoping Zou. Therapeutic potential of histone deacetylase inhibitors in pancreatic cancerCancer Letters 2014; 347(2): 183 doi: 10.1016/j.canlet.2014.02.012
10
Yusuke Kojima, Reeja S. Maskey, Yuichi J. Machida. Pancreatic Cancer2017; : 1 doi: 10.1007/978-1-4939-6631-8_74-1
11
Henry F. Duncan, Anthony J. Smith, Garry J. P. Fleming, Nicola C. Partridge, Emi Shimizu, Gary P. Moran, Paul R. Cooper. The Histone‐Deacetylase‐Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase‐13 ActivityJournal of Cellular Physiology 2016; 231(4): 798 doi: 10.1002/jcp.25128
12
Nianhong Chen, Qiaoqiao Zheng, Guoqing Wan, Feng Guo, Xiaobin Zeng, Ping Shi. Impact of posttranslational modifications in pancreatic carcinogenesis and treatmentsCancer and Metastasis Reviews 2021; 40(3): 739 doi: 10.1007/s10555-021-09980-4
13
Constantinos Giaginis, Christos Damaskos, Ioannis Koutsounas, Adamantia Zizi-Serbetzoglou, Nicolaos Tsoukalas, Efstratios Patsouris, Gregorios Kouraklis, Stamatios Theocharis. Histone deacetylase (HDAC)-1, −2, −4 and −6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients’ survivalBMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0379-y
14
Masumeh Sanaei, Fraidoon Kavoosi. Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various CancersAdvanced Biomedical Research 2019; 8(1): 63 doi: 10.4103/abr.abr_142_19
15
Xue-Song Xiang, Peng-Cheng Li, Wen-Quan Wang, Liang Liu. Histone deacetylases: A novel class of therapeutic targets for pancreatic cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(1): 188676 doi: 10.1016/j.bbcan.2022.188676
16
Min Kyu Jung. Nutritional Support for Patients with Pancreatic CancerThe Korean Journal of Gastroenterology 2019; 74(2): 87 doi: 10.4166/kjg.2019.74.2.87
17
Nabil A. Alhakamy, Shaimaa M. Badr-Eldin, Waleed S. Alharbi, Mohamed A. Alfaleh, Omar D. Al-hejaili, Hibah M. Aldawsari, Basma G. Eid, Rana Bakhaidar, Filippo Drago, Filippo Caraci, Giuseppe Caruso. Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic CellsPharmaceuticals 2021; 14(12): 1309 doi: 10.3390/ph14121309
18
Dharmalingam Subramaniam, Ravi Thombre, Animesh Dhar, Shrikant Anant. DNA Methyltransferases: A Novel Target for Prevention and TherapyFrontiers in Oncology 2014; 4 doi: 10.3389/fonc.2014.00080
19
Arshad Ali, Ayaz Ali, Hema S. Devi, Jayasimha R. Daddam, Rabiah Sarwar, Farheen Khan Badrealam. The HDAC2/YY1/c‐Myc signaling axis regulates lung cancer cell migration and proliferationEnvironmental Toxicology 2023; 38(8): 1989 doi: 10.1002/tox.23825
20
Kazuya Shimizu, Takaaki Nishiyama, Yuichi Hori. Gemcitabine Enhances Kras-MEK–Induced Matrix Metalloproteinase-10 Expression Via Histone Acetylation in Gemcitabine-Resistant Pancreatic Tumor-initiating CellsPancreas 2017; 46(2): 268 doi: 10.1097/MPA.0000000000000744
21
Xu Han, Tiantao Kuang, Yun Ren, Zhufeng Lu, Qingwu Liao, Wei Chen. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivoExperimental Cell Research 2019; 385(1): 111605 doi: 10.1016/j.yexcr.2019.111605
22
Shahrzad Movafagh, Amanda Munson. Epigenetics of Cancer Prevention2019; : 75 doi: 10.1016/B978-0-12-812494-9.00004-4
23
Bing Wang, Xin-bao Wang, Li-yu Chen, Ling Huang, Rui-zen Dong. Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axisBiochemical and Biophysical Research Communications 2013; 437(1): 1 doi: 10.1016/j.bbrc.2013.05.090
24
Kwai Fung Hui, Alan K.S. Chiang. Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanismInternational Journal of Cancer 2014; 135(12): 2950 doi: 10.1002/ijc.28924
25
Sally E. Henderson, Neil Makhijani, Thomas A. Mace. Pancreatic Cancer–Induced Cachexia and Relevant Mouse ModelsPancreas 2018; 47(8): 937 doi: 10.1097/MPA.0000000000001124
26
Marzieh Ramezani Farani, Maryam Sarlak, Amir Gholami, Maryam Azaraian, Maryam Moradi Binabaj, Sareh Kakavandi, Murtaza M. Tambuwala, Afshin Taheriazam, Mehrdad Hashemi, Sorayya Ghasemi. Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?Pathology - Research and Practice 2023; 248: 154688 doi: 10.1016/j.prp.2023.154688
27
Andrew E. Shouksmith, Fenil Shah, Michelle L. Grimard, Justyna M. Gawel, Yasir S. Raouf, Mulu Geletu, Angelika Berger-Becvar, Elvin D. de Araujo, H. Artee Luchman, William L. Heaton, David Bakhshinyan, Ashley A. Adile, Chitra Venugopal, Thomas O’Hare, Michael W. Deininger, Sheila K. Singh, Stephen F. Konieczny, Samuel Weiss, Melissa L. Fishel, Patrick T. Gunning. Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic CancerJournal of Medicinal Chemistry 2019; 62(5): 2651 doi: 10.1021/acs.jmedchem.8b01957
28
Hanieh Jafary, Shahin Ahmadian, Masoud Soleimani. The enhanced apoptosis and antiproliferative response to combined treatment with valproate and nicotinamide in MCF-7 breast cancer cellsTumor Biology 2014; 35(3): 2701 doi: 10.1007/s13277-013-1356-0
29
Yusuke Kojima, Reeja S. Maskey, Yuichi J. Machida. Pancreatic Cancer2018; : 19 doi: 10.1007/978-1-4939-7193-0_74
30
Deepkamal N. Karelia, Sangyub Kim, Manoj K. Pandey, Daniel Plano, Shantu Amin, Junxuan Lu, Arun K. Sharma. Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine CytotoxicityInternational Journal of Molecular Sciences 2021; 22(9): 4966 doi: 10.3390/ijms22094966
31
Ammar Abdul Aziz Alibeg, Mohammed Hassan Mohammed. Design, synthesis, insilco study and biological evaluation of new isatin-sulfonamide derivatives by using mono amide linker as possible as histone deacetylase inhibitorsPolski Merkuriusz Lekarski 2024; 52(2): 178 doi: 10.36740/Merkur202402106
32
Immacolata Maietta, Amparo Martínez-Pérez, Rosana Álvarez, Ángel R. De Lera, África González-Fernández, Rosana Simón-Vázquez. Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer CellsPharmaceuticals 2022; 15(7): 824 doi: 10.3390/ph15070824
33
Ronald-Allan Panganiban, Andrew Snow, Regina Day. Mechanisms of Radiation Toxicity in Transformed and Non-Transformed CellsInternational Journal of Molecular Sciences 2013; 14(8): 15931 doi: 10.3390/ijms140815931
34
Sally E. Henderson, Li-Yun Ding, Xiaokui Mo, Tanios Bekaii-Saab, Samuel K. Kulp, Ching-Shih Chen, Po-Hsien Huang. Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42Neoplasia 2016; 18(12): 765 doi: 10.1016/j.neo.2016.10.003
35
Andee Weisbeck, Rick Jansen. Nutrients and the Pancreas: An Epigenetic PerspectiveNutrients 2017; 9(3): 283 doi: 10.3390/nu9030283